Navigation Links
Mannatech Names New VP of Regulatory Affairs, Quality Assurance
Date:1/29/2008

Berkley brings more than 25 years of industry experience

COPPELL, Texas, Jan. 29 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, today announced the hiring of Marika Berkley as the company's vice president of global regulatory affairs and quality assurance.

"We are extremely pleased to announce Marika's addition to our management team," said Terry O'Day, executive vice president and COO of Mannatech. "Marika has a strong background in regulated health care industries in developing, implementing and maintaining quality systems used to achieve compliance with regulatory requirements. Her experience will be a valuable asset as we expand our international presence."

Having previously been the department head for the Quality Assurance and Regulatory Affairs disciplines, Berkley's experience includes directing all components of these functions, including strategic business development, ISO implementation, regulatory compliance, supply chain partnerships and auditing. In addition to her technical expertise, Berkley has vast experience in leading and developing teams, and in her own words, she is "particularly skilled in developing high performance interdisciplinary teams" -- something she looks forward to with the combining of the Quality Assurance and Regulatory Affairs departments.

Berkley's international experience includes Europe, Asia, Latin America and the Pacific Rim. Prior to joining Mannatech, Berkley worked for the Gillette Company, Abbott Labs and PFIZER Laboratories. Most recently, she was the Vice President of Quality Assurance and Regulatory Affairs for Facet Technologies, LLC, in Atlanta, Georgia.

Berkley graduated with a bachelor's of science degree in biology and chemistry from City University of New York.

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information:

Gary Spinell, Vice President

Investor Relations

972-471-6512

ir@mannatech.com

Corporate website: http://www.mannatech.com


'/>"/>
SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech to Open Centralized-Management Office in Switzerland
2. Mannatech Hosts Australasian Convention
3. Mannatech Hosts Japan National Convention
4. Mannatech Launches Phase One of New Sales and Training Tools
5. AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
6. American Media, Inc. Names Dean Durbin Executive Vice President and Chief Financial Officer
7. Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board
8. Fleishman-Hillard Names FFI Global Cause for 2008
9. International Isotopes Inc. Names James Mayer as Chief Operating Officer
10. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
11. LearnSomething Names Deborah Faucette to New Position of Senior Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: